Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
14.72
+0.27 (1.87%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Arcutis Biotherapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$18.80
Upside
+27.72%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +35.87% | Apr 9, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Apr 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +29.08% | Apr 3, 2025 |
| Needham | Needham | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +35.87% | Apr 3, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $16 → $19 | Strong Buy | Maintains | $16 → $19 | +29.08% | Mar 11, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | +1.90% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +29.08% | Feb 26, 2025 |
| Mizuho | Mizuho | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +42.66% | Feb 26, 2025 |
| Needham | Needham | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +35.87% | Feb 26, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Feb 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +29.08% | Jan 13, 2025 |
| Mizuho | Mizuho | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +35.87% | Jan 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +29.08% | Dec 30, 2024 |
| Needham | Needham | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +35.87% | Dec 17, 2024 |
| Needham | Needham | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +22.28% | Nov 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.